EULAR/ACR Releases Points-to-Consider for Management of Autoinflammatory Type I Interferonopathies (CANDLE/PRAAS, SAVI, and AGS)
The EULAR and ACR developed evidence-based guidance and points-to-consider for the diagnosis and management of patients with CANDLE/PRAAS, SAVI, and AGS.